Abstract
One of the most elusive goals in the modern medical era has been to design a safe and effective asanquinous oxygen therapeutic (OT). After 80 years of research and dozens of clinical trials, most of the 17 billion people in the world are still without an alternative to blood; South Africa and Russia are currently the rare exceptions (Amberson 1933; www.opkbiotech.com, 2012).
Cite
CITATION STYLE
Moon-Massat, P., & Freilich, D. (2014). Compassionate use cases treated with hemoglobin-based oxygen carriers. In Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics (Vol. 9783642407178, pp. 563–584). Springer-Verlag Berlin Heidelberg. https://doi.org/10.1007/978-3-642-40717-8_31
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
